ampicillin has been researched along with cefotetan in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (22.73) | 18.7374 |
| 1990's | 8 (36.36) | 18.2507 |
| 2000's | 4 (18.18) | 29.6817 |
| 2010's | 5 (22.73) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Kanamori, M; Kirikae, T; Kitao, T; Miyoshi-Akiyama, T; Morita, K; Okazaki, M; Sekiguchi, J; Watanabe, N | 1 |
| Arakawa, Y; Ishikawa, K; Nagano, N; Nagano, Y; Wachino, J | 1 |
| Baptista, BC; Correia, JD; da Fonseca, JD; Martínez-Martínez, L; Pomba, C | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Borgianni, L; Docquier, JD; Hanson, ND; Prandi, S; Rossolini, GM; Salden, L; Santella, G | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Cheramie, MN; Cherian, PT; Fernando, DM; Hurdle, JG; Lee, RE; Marreddy, RKR | 1 |
| Ahmet, Z; Houang, ET | 1 |
| Brook, I | 3 |
| Canale, MP; Carrera, S; Mangioni, C; Milani, R; Negri, L; Norchi, S; Regallo, M; Ruffilli, MP; Scalambrino, S; Vigano, EF | 1 |
| Baker, LW; Francis, AJ; Francis, GM; Huizinga, WK; Kadwa, H; van den Ende, J | 1 |
| Andriole, VT; Sochalski, A; Sullman, S | 1 |
| Greig, J; Gunn, R; Haddock, G; Mason, B; McArdle, C; Morran, C; Sleigh, J | 1 |
| Barefoot, L; Falagas, ME; Griffith, J; Ruthazar, R; Snydman, DR | 1 |
| Huilgol, VR; Markus, SL; Vakil, NB | 1 |
| Bracero, LA | 1 |
| Bergstrom, R; Mueller, G; Yankowitz, J | 1 |
| Berkeley, AS; Freedman, K; Ledger, W; Noyes, N | 1 |
| Bonfill Cosp, X; Chapman, E; Illanes, E; Reveiz, L | 1 |
3 review(s) available for ampicillin and cefotetan
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Antibiotic-induced iatrogenic hemobilia.
Topics: Aged; Aged, 80 and over; Ampicillin; Cefotetan; Cephamycins; Cholecystitis; Drug Therapy, Combination; Female; Hemobilia; Humans; Iatrogenic Disease; Sulbactam; Vitamin K Deficiency | 1997 |
Antibiotic regimens for management of intra-amniotic infection.
Topics: Amnion; Ampicillin; Anti-Bacterial Agents; Cefotetan; Chorioamnionitis; Clindamycin; Delivery, Obstetric; Drug Administration Schedule; Endometritis; Female; Fetal Diseases; Gentamicins; Humans; Postpartum Period; Pregnancy; Sepsis; Sulbactam | 2014 |
6 trial(s) available for ampicillin and cefotetan
| Article | Year |
|---|---|
Intraoperative wound contamination during abdominal hysterectomy.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Cefotetan; Drug Therapy, Combination; Female; Humans; Hysterectomy; Intraoperative Period; Metronidazole; Surgical Wound Infection | 1991 |
Sulbactam/ampicillin versus cefotetan in the treatment of obstetric and gynecologic infections.
Topics: Adult; Aged; Ampicillin; Bacterial Infections; Cefotetan; Drug Therapy, Combination; Female; Genital Diseases, Female; Humans; Middle Aged; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Sulbactam | 1989 |
Management of severe intra-abdominal sepsis: single agent antibiotic therapy with cefotetan versus combination therapy with ampicillin, gentamicin and metronidazole.
Topics: Abdomen; Adolescent; Adult; Aged; Ampicillin; Ascitic Fluid; Bacterial Infections; Cefotetan; Clinical Trials as Topic; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Random Allocation | 1988 |
Comparison of cefotetan and gentamicin/ampicillin in high-risk biliary tract surgery.
Topics: Ampicillin; Biliary Tract Diseases; Cefotetan; Clinical Trials as Topic; Drug Therapy, Combination; Gentamicins; Humans; Random Allocation; Risk Factors; Sepsis; Surgical Wound Infection | 1987 |
Ampicillin/sulbactam versus cefotetan for the prevention of infection following cesarean delivery in high-risk patients: a randomized double-blind trial.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Cefotetan; Cephamycins; Cesarean Section; Double-Blind Method; Female; Humans; Infection Control; Penicillins; Postoperative Complications; Pregnancy; Sulbactam | 1997 |
Incidence of postpartum endomyometritis following single-dose antibiotic prophylaxis with either ampicillin/sulbactam, cefazolin, or cefotetan in high-risk cesarean section patients.
Topics: Adult; Ampicillin; Antibiotic Prophylaxis; Cefazolin; Cefotetan; Cephalosporins; Cephamycins; Cesarean Section; Drug Therapy, Combination; Endometritis; Extraembryonic Membranes; Female; Hospitals, University; Humans; Labor, Obstetric; Postpartum Period; Pregnancy; Prospective Studies; Sulbactam | 1998 |
13 other study(ies) available for ampicillin and cefotetan
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
KHM-1, a novel plasmid-mediated metallo-beta-lactamase from a Citrobacter freundii clinical isolate.
Topics: Amino Acid Sequence; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Citrobacter freundii; Conjugation, Genetic; DNA Primers; DNA, Bacterial; Enterobacteriaceae Infections; Escherichia coli K12; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Plasmids; Recombinant Proteins; Sequence Homology, Amino Acid | 2008 |
Novel chimeric beta-lactamase CTX-M-64, a hybrid of CTX-M-15-like and CTX-M-14 beta-lactamases, found in a Shigella sonnei strain resistant to various oxyimino-cephalosporins, including ceftazidime.
Topics: Amino Acid Sequence; beta-Lactamases; Blotting, Southern; Ceftazidime; Cephalosporins; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Homology, Amino Acid; Shigella sonnei | 2009 |
Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6')-Ib-cr genes in a dog.
Topics: Animals; Anti-Bacterial Agents; Dogs; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Humans; Plasmids; Virulence | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Genetic context and biochemical characterization of the IMP-18 metallo-beta-lactamase identified in a Pseudomonas aeruginosa isolate from the United States.
Topics: Amino Acid Sequence; Bacterial Proteins; beta-Lactamases; beta-Lactams; Ertapenem; Meropenem; Microbial Sensitivity Tests; Models, Genetic; Molecular Sequence Data; Open Reading Frames; Pseudomonas aeruginosa; Sequence Homology, Amino Acid; Thienamycins; United States | 2011 |
New β-lactam - Tetramic acid hybrids show promising antibacterial activities.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Escherichia coli; Klebsiella pneumoniae; Lactams; Microbial Sensitivity Tests; Molecular Structure; Pyrrolidinones; Staphylococcus aureus; Structure-Activity Relationship | 2018 |
In vitro susceptibility and in vivo efficacy of antimicrobials in the treatment of Bacteroides fragilis-Escherichia coli infection in mice.
Topics: Abscess; Ampicillin; Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; Cefamandole; Cefotetan; Cefoxitin; Ceftizoxime; Cilastatin; Cilastatin, Imipenem Drug Combination; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Imipenem; Male; Mice; Skin Diseases; Sulbactam | 1989 |
Cost-effectiveness study of cefotetan versus cefoxitin and cefotetan versus combination antibiotic regimens.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Cefotetan; Cefoxitin; Cephamycins; Cost-Benefit Analysis; Costs and Cost Analysis; Drug Therapy, Combination; Humans; Metronidazole; Retrospective Studies | 1988 |
Comparison of cefoxitin, cefotetan, and ampicillin/sulbactam as prophylaxis for polymicrobial infection in mice.
Topics: Abscess; Ampicillin; Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; Cefotetan; Cefoxitin; Cephamycins; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Male; Mice; Mice, Inbred C3H; Microbial Sensitivity Tests; Penicillins; Peritoneal Diseases; Sulbactam | 1995 |
Comparison of cefoxitin, cefotetan and the combination of ampicillin with sulbactam in the therapy of polymicrobial infection in mice.
Topics: Ampicillin; Animals; Bacterial Infections; Cefotetan; Cefoxitin; Drug Therapy, Combination; Male; Mice; Mice, Inbred C3H; Microbial Sensitivity Tests; Sulbactam | 1994 |
Risk factors leading to clinical failure in the treatment of intra-abdominal or skin/soft tissue infections.
Topics: Abdominal Abscess; Adult; Age Factors; Aged; Ampicillin; Anti-Bacterial Agents; Cefotetan; Cefoxitin; Cephamycins; Drug Resistance, Microbial; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Matched-Pair Analysis; Middle Aged; Multivariate Analysis; Penicillins; Pseudomonas Infections; Retrospective Studies; Risk Factors; Sex; Skin Diseases, Bacterial; Soft Tissue Infections; Sulbactam; Treatment Outcome | 1996 |
A case illustrating the continued dilemmas in treating abdominal pregnancy and a potential explanation for the high rate of postsurgical febrile morbidity.
Topics: Adult; Ampicillin; Cefotetan; Cephamycins; Female; Fetal Death; Fever; Humans; Penicillins; Peritoneal Diseases; Pregnancy; Pregnancy, Abdominal; Streptococcal Infections; Streptococcus agalactiae | 1998 |